Gc. Bird et al., Modulation of primary afferent-mediated neurotransmission and Fos expression by glutamate uptake inhibition in rat spinal neurones in vitro, NEUROPHARM, 41(5), 2001, pp. 582-591
The effect of altered endogenous levels of synaptic glutamate on neurotrans
mission and synaptic dorsal horn Fos expression was determined in rat spina
l cord in vitro. The uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxy lat
e (L-PDC, 1 mM) was tested against dorsal root-ventral root potentials (DR-
VRP), afferent-mediated slow dorsal horn excitatory postsynaptic potentials
(DR-EPSP) and nociceptive afferent-induced synaptic currents (EPSCs) of su
bstantia gelatinosa neurones. L-PDC reduced DR-VRP fast and slow peak ampli
tude and duration (P<0.05), slow DR-EPSP amplitude and duration (P<0.005) a
nd EPSC amplitude (P<0.05). The Group II/III mGluR antagonist (RS)-<alpha>-
cyclopropyl-4-phosphonophenylglycine (CPPG, 100 muM) reduced L-PDC inhibiti
on of synaptic potentials. The Group II antagonist (2S)-2-amino-2-(1S,2S-2-
carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495, 300 nM) and
the Group III antagonist (RS)-alpha -methylserine-O-phosphate (MSOP, 10 muM
) partially reversed EPSC inhibition by L-PDC. The Group III agonist L(+)-2
-amino-4-phosphonobutyric acid (L-AP4, 30 muM) mimicked CPPG-sensitive inhi
bitory effects Of L-PDC on DR-VPP (P<0.001) and the slow DR-EPSP (P<0.005).
L-PDC (1 mM) or L-AP4 (30 muM) reduced afferent-evoked dorsal horn Fos exp
ression, this effect was reversed by CPPG. These data suggest that increase
d synaptic glutamate levels may activate inhibitory Group II/III mGluR rece
ptors and impact significantly on nociceptive neurotransmission and transcr
iptional adaptive responses of target neurones. (C) 2001 Elsevier Science L
td.